Mainstay Medical Forges New Path In Neurostim

Mainstay Medical is targeting a large population of underserved chronic pain sufferers with a unique implantable device that breaks new ground in the neurostimulation arena.

Cover of MedTech Strategist Publication with Mainstay Medical Feature

You just clicked on a link to go to another Mainstay Medical ("Mainstay") website that is different from your current website, which is specifically intended for your country/region.  Please note there may be important differences on Mainstay websites designed for other countries/regions, including information about product (ReActiv8) indication and use, regulatory approval, healthcare practice standards, and data protection laws, among other things.  Do you still wish to continue to the different site?